戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 efficacy and safety of raltegravir, an HIV-1 integrase strand-transfer inhibitor.
2  reverse transcriptase inhibitors [NNRTIs]), integrase strand transfer inhibitors, and virus entry in
3                                        HIV-1 integrase strand transfer inhibitors are an important cl
4                                 Specific HIV integrase strand transfer inhibitors are thought to bind
5  present the discovery of a new class of HIV integrase strand transfer inhibitors based on the 2-pyri
6 , and tenofovir alafenamide is a once-daily, integrase strand transfer inhibitor-based regimen approv
7                 In phase 1 trials, the HIV-1 integrase strand transfer inhibitor cabotegravir (GSK126
8 d single or boosted drug, which should be an integrase strand transfer inhibitor (dolutegravir, elvit
9                                      The HIV integrase strand transfer inhibitor elvitegravir (EVG) h
10        Dolutegravir (DTG), a next-generation integrase strand transfer inhibitor (INSTI), was recentl
11      The base case prevalence of transmitted integrase strand transfer inhibitor (INSTI)-resistant (I
12                            The prevalence of integrase strand transfer inhibitor (INSTI)-transmitted
13 rse transcriptase inhibitors (NRTIs) plus an integrase strand transfer inhibitor (InSTI).
14                                              Integrase strand transfer inhibitors (INSTIs) are highly
15                                              Integrase strand transfer inhibitors (INSTIs) are recomm
16    All recent treatment guidelines recommend integrase strand transfer inhibitors (INSTIs) as compone
17                                              Integrase strand transfer inhibitors (INSTIs) coadminist
18 iveness of the first-generation FDA-approved integrase strand transfer inhibitors (INSTIs), raltegrav
19                 Resistance to raltegravir in integrase strand transfer inhibitor-naive patients remai
20 e inhibitor (atazanavir or darunavir), or an integrase strand transfer inhibitor (raltegravir).
21                    GSK1265744 (GSK744) is an integrase strand-transfer inhibitor that has been formul
22                 Dolutegravir is a once-daily integrase strand transfer inhibitor with no need for pha
23        Cabotegravir (GSK1265744) is an HIV-1 integrase strand transfer inhibitor with potent antivira
24 s of integration and how clinically relevant integrase strand transfer inhibitors work.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。